Medtrum to debut S10 CGM at EASD 2026
Medtrum will preview its new S10 continuous glucose monitor at EASD 2026 in Milan, showing a smaller all-in-one sensor built for the TouchCare Nano System. The device is designed to pair with Medtrum’s Nano tubeless pump and deliver glucose updates every two minutes for up to 14 days.
Why it matters: - Medtrum is pushing toward a more compact automated insulin delivery setup with fewer wearable parts. - The S10 is designed to make continuous glucose monitoring and tubeless insulin delivery easier to wear and more discreet for people with diabetes.
What happened: - Medtrum will preview the S10 CGM at EASD 2026 in Milan from 29 September to 1 October. - The device will be shown at Booth H.03 at Allianz MiCo alongside the Nano Pump. - The S10 is the newest CGM in Medtrum’s portfolio and the next step in the TouchCare Nano System.
The details: - The S10 is circular, measures 16 mm in diameter and weighs about 1 gram. - The CGM is an all-in-one wearable, so it does not use a separate reusable transmitter. - The S10 offers up to 14 days of wear. - The device updates glucose readings every two minutes. - People using the S10 can view glucose data on a compatible smartphone. - The S10 is designed to work with Medtrum’s Nano Pump. - When paired with the Nano 200U tubeless insulin pump, the system uses two small on-body devices with no tubing. - Medtrum founder and CEO Scott Yang said the S10 moves the electronics and battery inside the sensor itself, with nothing separate to charge or pair, while keeping the connectivity central to the AID system. - Medtrum says the TouchCare Nano System uses the company’s APGO advanced closed-loop artificial pancreas algorithm.
Between the lines: - The product points to a broader industry push to shrink diabetes tech without losing automation or connectivity. - Medtrum is emphasizing convenience and discretion as much as glucose monitoring performance. - The launch preview also signals that Medtrum is continuing to build out its connected diabetes platform around a smartphone app and on-body devices. - Medtrum says its products are available in more than 50 countries and regions and covered by reimbursement systems in more than 20 European countries, including the UK, France, Germany, Italy, the Netherlands and the Nordic countries.
What's next: - Visitors can inspect the S10 and Nano Pump in Milan during the EASD 2026 conference window. - Medtrum is positioning the S10 as part of the next generation of its diabetes technology lineup. - The company is expected to use the EASD showcase to build interest ahead of wider market rollout details, which were not disclosed.
The bottom line: - Medtrum’s S10 aims to make automated diabetes care smaller, simpler and more integrated, while keeping the core connected features of its current system.**
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Consumer News: Italy
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.